249 related articles for article (PubMed ID: 25059663)
1. TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.
Ikeuchi Y; Dadakhujaev S; Chandhoke AS; Huynh MA; Oldenborg A; Ikeuchi M; Deng L; Bennett EJ; Harper JW; Bonni A; Bonni S
J Biol Chem; 2014 Sep; 289(36):25067-78. PubMed ID: 25059663
[TBL] [Abstract][Full Text] [Related]
2. Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells.
Netherton SJ; Bonni S
PLoS One; 2010 Nov; 5(11):e13971. PubMed ID: 21103059
[TBL] [Abstract][Full Text] [Related]
3. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner.
Chandhoke AS; Karve K; Dadakhujaev S; Netherton S; Deng L; Bonni S
Cell Death Differ; 2016 May; 23(5):876-88. PubMed ID: 26679521
[TBL] [Abstract][Full Text] [Related]
5. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
6. SnoN suppresses TGF-β-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1γ-dependent manner.
Yin X; Xu C; Zheng X; Yuan H; Liu M; Qiu Y; Chen J
Oncol Rep; 2016 Sep; 36(3):1535-41. PubMed ID: 27430247
[TBL] [Abstract][Full Text] [Related]
7. TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling.
Fattet L; Ay AS; Bonneau B; Jallades L; Mikaelian I; Treilleux I; Gillet G; Hesling C; Rimokh R
J Cell Sci; 2013 Aug; 126(Pt 16):3713-23. PubMed ID: 23788427
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT.
Soond SM; Chantry A
Oncogene; 2011 May; 30(21):2451-62. PubMed ID: 21258410
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
[TBL] [Abstract][Full Text] [Related]
10. Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells.
Sengupta S; Jana S; Biswas S; Mandal PK; Bhattacharyya A
Clin Exp Metastasis; 2013 Dec; 30(8):1019-31. PubMed ID: 23832742
[TBL] [Abstract][Full Text] [Related]
11. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
[TBL] [Abstract][Full Text] [Related]
12. Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.
Erker Y; Neyret-Kahn H; Seeler JS; Dejean A; Atfi A; Levy L
Mol Cell Biol; 2013 Jun; 33(11):2163-77. PubMed ID: 23530056
[TBL] [Abstract][Full Text] [Related]
13. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase CK2 activation is required for transforming growth factor β-induced epithelial-mesenchymal transition.
Kim S; Ham S; Yang K; Kim K
Mol Oncol; 2018 Oct; 12(10):1811-1826. PubMed ID: 30171795
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells.
Hesling C; Fattet L; Teyre G; Jury D; Gonzalo P; Lopez J; Vanbelle C; Morel AP; Gillet G; Mikaelian I; Rimokh R
EMBO Rep; 2011 Jul; 12(7):665-72. PubMed ID: 21597466
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation.
Wrighton KH; Liang M; Bryan B; Luo K; Liu M; Feng XH; Lin X
J Biol Chem; 2007 Mar; 282(9):6517-24. PubMed ID: 17202138
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells.
Oh E; Kim JY; Sung D; Cho Y; Lee N; An H; Kim YJ; Cho TM; Seo JH
Cell Signal; 2017 Aug; 36():230-239. PubMed ID: 28499884
[TBL] [Abstract][Full Text] [Related]
19. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
20. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]